ProfileGDS4718 / 202253_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 90% 90% 75% 91% 88% 81% 79% 90% 90% 91% 89% 89% 82% 79% 83% 86% 88% 79% 80% 77% 89% 91% 90% 90% 88% 82% 90% 74% 90% 77% 82% 73% 90% 92% 80% 73% 80% 89% 91% 70% 90% 79% 76% 78% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.3130690
GSM549102patient 115, normal, homogenized [OPG study]9.1992790
GSM549104patient 119, normal, homogenized [OPG study]7.4016975
GSM549108patient 138, normal, homogenized [OPG study]9.2766891
GSM549119patient 077, normal, homogenized [OPG study]8.7982288
GSM549133patient 032, cancer, homogenized [OPG study]8.082681
GSM549139patient 042, cancer, homogenized [OPG study]7.7925379
GSM549099patient 107, normal, homogenized [OPG study]9.2140690
GSM549109patient 139, normal, homogenized [OPG study]9.2857490
GSM549110patient 046, normal, homogenized [OPG study]9.3980891
GSM549114patient 063, normal, homogenized [OPG study]9.1797589
GSM549122patient 082, normal, homogenized [OPG study]9.0403589
GSM549134patient 033, cancer, homogenized [OPG study]8.0877782
GSM549136patient 036, cancer, homogenized [OPG study]7.8437479
GSM549140patient 044, cancer, homogenized [OPG study]8.3047383
GSM549111patient 047, normal, homogenized [OPG study]8.716386
GSM549113patient 057, normal, homogenized [OPG study]9.1077488
GSM549132patient 031, cancer, homogenized [OPG study]7.7988279
GSM549137patient 038, cancer, homogenized [OPG study]7.9189880
GSM549142patient 047, cancer, homogenized [OPG study]7.3560977
GSM549100patient 110, normal, homogenized [OPG study]9.0592489
GSM549107patient 135, normal, homogenized [OPG study]9.3955591
GSM549115patient 068, normal, homogenized [OPG study]9.4085990
GSM549116patient 072, normal, homogenized [OPG study]9.2280890
GSM549120patient 078, normal, homogenized [OPG study]8.8769188
GSM549131patient 030, cancer, homogenized [OPG study]8.1770682
GSM549118patient 074, normal, homogenized [OPG study]9.2146890
GSM549129patient 027, cancer, homogenized [OPG study]7.3420674
GSM549123patient 088, normal, homogenized [OPG study]9.2083390
GSM549124patient 006, cancer, homogenized [OPG study]7.510577
GSM549126patient 015, cancer, homogenized [OPG study]8.1199782
GSM549128patient 025, cancer, homogenized [OPG study]7.253673
GSM549103patient 117, normal, homogenized [OPG study]9.1152890
GSM549117patient 073, normal, homogenized [OPG study]9.6626592
GSM549138patient 041, cancer, homogenized [OPG study]7.9411380
GSM549141patient 045, cancer, homogenized [OPG study]7.226973
GSM549130patient 028, cancer, homogenized [OPG study]7.8580580
GSM549101patient 111, normal, homogenized [OPG study]8.9134289
GSM549105patient 128, normal, homogenized [OPG study]9.2544691
GSM549106patient 134, normal, homogenized [OPG study]6.9177870
GSM549112patient 048, normal, homogenized [OPG study]9.2322590
GSM549125patient 011, cancer, homogenized [OPG study]7.6952679
GSM549127patient 024, cancer, homogenized [OPG study]7.5372776
GSM549135patient 035, cancer, homogenized [OPG study]7.7284778